Gastrointestinal toxicity of transperineal interstitial prostate brachytherapy

International Journal of Radiation Oncology Biology Physics

Volumn 53, Issue 1, 2002, Pages 99-103

  Kang, Song K ^a   Chou, Rachel H ^a,b   Dodge, Richard K ^a   Clough, Robert W ^a   Kang, Hi Sung L ^a   Hahn, Carol A ^a,b   Whitehurst, Arthur W ^b   Buckley, Niall J ^b   Kim, Jay H ^b   Joyner, Raymond E ^b   Montana, Gustavo S ^a   Ingram, Sally S ^a   Anscher, Mitchell S ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Durham Regional Hospital   (United States)

Author keywords

Brachytherapy; Complications; Prostate cancer; Rectal

Indexed keywords

ANTIGENS; GASTROENTEROLOGY; IODINE; ONCOLOGY; TOXICITY; TUMORS;

EXTERNAL BEAM RADIATION;

RADIOTHERAPY;

IODINE 125; PALLADIUM 103; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; BEAM THERAPY; CANCER INCIDENCE; CAUCASIAN; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; INTERSTITIAL RADIATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; RACE DIFFERENCE; RISK FACTOR; SYMPTOM;

ADULT; AGED; BRACHYTHERAPY; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PALLADIUM; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOISOTOPES; RECTAL DISEASES; REGRESSION ANALYSIS;

EID: 0036570302     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)02811-5     Document Type: Conference Paper

References (16)

1. The National Cancer Data base report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S
2. Prostate brachytherapy: Increasing demand for the procedure despite the lack of standardized quality assurance and long term outcome data
3. Acute urinary toxicity following transperineal prostate brachytherapy using a modified Quimby loading method
4. Clinical course of rectal bleeding following I-125 prostate brachytherapy
5. Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer
6. Three dimensional conformal radiotherapy for the treatment of prostate cancer: Low risk of chronic rectal morbidity observed in a large series of patients
7. Acute toxicity of three-dimensional conformal radiotherapy in prostate cancer patients eligible for implant monotherapy
8. Standard vs. conformal radiation therapy for adenocarcinoma of the prostate: No difference
9. Modified uniform seed loading for prostate brachytherapy: Rationale, design, and evaluation
10. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy
11. 125I prostate implantation
12. Transperineal palladium 103 prostate brachytherapy: Analysis of morbidity and seed migration
13. Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma
14. Prostate brachytherapy: Treatment strategies
15. Quality of life in T1-3N0 prostate cancer patients treated with radiation therapy with minimum 10-year follow-up
16. A preliminary analysis of health-related quality of life in the first year after permanent source interstitial brachytherapy (PIB) for clinically localized prostate cancer